Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.2%

2 terminated out of 62 trials

Success Rate

92.6%

+6.1% vs benchmark

Late-Stage Pipeline

19%

12 trials in Phase 3/4

Results Transparency

16%

4 of 25 completed with results

Key Signals

4 with results93% success

Data Visualizations

Phase Distribution

33Total
Not Applicable (14)
Early P 1 (3)
P 1 (1)
P 2 (3)
P 3 (5)
P 4 (7)

Trial Status

Completed25
Unknown18
Recruiting9
Withdrawn5
Not Yet Recruiting2
Terminated2

Trial Success Rate

92.6%

Benchmark: 86.5%

Based on 25 completed trials

Clinical Trials (62)

Showing 20 of 20 trials
NCT03535272Phase 3Terminated

Bismuth Subsalicylate's Role in the Prevention of Travelers' Diarrhea

NCT06214403Phase 2Withdrawn

Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation

NCT07172932Completed

ANTIBIOTIC-RESISTANT ENTEROBACTERALES BLOODSTREAM INFECTIONS AND RISK FACTORS IN PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT

NCT03452839Phase 4CompletedPrimary

Bolus Versus Continuous Infusion of Meropenem

NCT05169229Phase 2Recruiting

Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement.

NCT05871476Not ApplicableRecruitingPrimary

Interventions to Decrease CRE Colonization and Transmission Between Hospitals, Households, Communities and Domesticated Animals

NCT03865706Phase 2CompletedPrimary

Inulin for Infections in the Intensive Care Unit

NCT06824350Not ApplicableRecruiting

Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates

NCT05950984Completed

Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)

NCT06672471Not ApplicableEnrolling By Invitation

Post-Operative Antibiotic Efficacy in Clean Contaminated Head and Neck Surgery: A Randomized Controlled Trial

NCT02922998CompletedPrimary

CD64 and Antibiotics in Human Sepsis

NCT05502380Phase 3Recruiting

Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery

NCT06607887Phase 4Recruiting

The Role of Postoperative Antibiotics in Laparoscopic Cholecystectomy

NCT04785924Phase 4Withdrawn

Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections

NCT05667207Not ApplicableCompleted

Dipsticks and Microscopy to Reduce Antibiotic Use in Women's Urinary Tract Infections: a Pilot Trial (MicUTI)

NCT05391035Completed

The Antibiotic Guardian Study- Clinical Evaluation of a Novel, Rapid Diagnostic for Gonorrhoea and Mycoplasma Infections.

NCT04462133Not ApplicableWithdrawn

Optimal Tailored Treatment for H. Pylori Infection

NCT03305627Not ApplicableCompleted

Optimized Perioperative Antibiotic Prophylaxis in Radical Cystectomy

NCT06383637Not Yet Recruiting

Antibiotic Use and Resistance KAP Among Dental Interns

NCT05712733Recruiting

Cholecystitis From a Microbiological and Histopathological Perspective

Scroll to load more

Research Network

Activity Timeline